Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03301220
What this trial is testing

Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Janssen Research & Development, LLC 390
Not applicableNot Yet RecruitingNCT07797270
What this trial is testing

Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas

Who this might be right for
Lipoma
Chinese PLA General Hospital 30
Early research (Phase 1)Ended earlyNCT03427073
What this trial is testing

A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours

Who this might be right for
Solid TumorsOvarian Cancer
Almac Discovery 20
Testing effectiveness (Phase 2)Study completedNCT01696461
What this trial is testing

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Who this might be right for
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Center for International Blood and Marrow Transplant Research 127
Not applicableStudy completedNCT04127149
What this trial is testing

Evaluation of Ultra-portable Ultrasound in General Practice

Who this might be right for
PneumoniaPleural EffusionRenal Colic+5 more
Hospices Civils de Lyon 166
Not applicableUnknownNCT02686918
What this trial is testing

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse

Who this might be right for
Breast Neoplasms
Institut de Cancérologie de la Loire 100
Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Not applicableLooking for participantsNCT06830759
What this trial is testing

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaFollicular Lymphoma
AbbVie 700
Not applicableEnded earlyNCT01551082
What this trial is testing

Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Who this might be right for
Lung CancerPneumothoraxSubcutaneous Emphysema
Alliance of Cardiothoracic and Vascular Surgeons 12
Early research (Phase 1)Active Not RecruitingNCT05206357
What this trial is testing

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Who this might be right for
Non-hodgkin Lymphoma
Genmab 17
Testing effectiveness (Phase 2)WithdrawnNCT00293527
What this trial is testing

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

Who this might be right for
Renal Cancer
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT06212752
What this trial is testing

Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT03248843
What this trial is testing

PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
3D Medicines (Sichuan) Co., Ltd. 35
Early research (Phase 1)Ended earlyNCT04311710
What this trial is testing

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

Who this might be right for
Tumor
Bristol-Myers Squibb 21
Early research (Phase 1)Study completedNCT01844869
What this trial is testing

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Who this might be right for
Hematologic MalignanciesSolid Tumors
Teva Branded Pharmaceutical Products R&D, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01257425
What this trial is testing

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

Who this might be right for
Prostate Cancer
Ipsen 109
Testing effectiveness (Phase 2)Study completedNCT00565981
What this trial is testing

A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Testing effectiveness (Phase 2)Ended earlyNCT01390545
What this trial is testing

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Takeda 300
Early research (Phase 1)Study completedNCT00002687
What this trial is testing

Interleukin-2 in Treating Patients With Mycosis Fungoides

Who this might be right for
Lymphoma
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00071396
What this trial is testing

Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 48
Next Page